Another advantage of our approach is the evolutionarily conserved effects of 5-FU on host metabolism, at similar physiological drug concentrations to that observed in human plasma after treatment or at concentrations capable of inhibiting TS in colon cancer cells (Ser et al., 2016). This evidence concerns the gene TYMS and colonic neoplasm.